About Michael Kaseta
Michael Kaseta is a director at Bryn Pharma.
Form D filings also name Michael Kaseta as a chief financial officer at Aerami Therapeutics Holdings.
Michael Kaseta first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Kaseta in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Kaseta works with at each company, as listed on that company's latest Form D.
Bryn Pharma, Inc. · Form D, Aug 14, 2025
AW
Anne Whitaker
Director
JH
Jeff Hartness
Director
SH
Steven Hartman
Director
JZ
Joshua Ziel
Executive officer
ML
Michelle Lobel
Director
SK
MR
Marc Rapaport
Director
LL
Lisa Licht
Director
SL
Sandra Loreaux
Director
JB
James Borneman
Executive officer
KD
Kate Soper Diaz
Director
Aerami Therapeutics Holdings, Inc. · Form D, Jun 17, 2020
KJ
Kenneth Lee, Jr.
Director
TC
Timm Crowder
Executive officer
AW
Anne Whitaker
Executive officer and director
BW
Bill Welch
Director
BW
Benjamin Wolin
Director
ST
Steve Thornton
Director
JP
John Patton
Director
AS
Adam Stern
Director